Death certificates compared to SEER-Medicare data for surveillance of liver cancer mortality due to hepatitis B or hepatitis C infection

被引:3
|
作者
Jiang, Joy J. [1 ]
Shiels, Meredith S. [1 ]
O'Brien, Thomas R. [1 ]
机构
[1] NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, 9609 Med Ctr Dr,6E108,MSC 9767, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
cause of death; hepatitis B virus; hepatitis C virus; liver cancer; surveillance;
D O I
10.1111/jvh.13498
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatocellular carcinoma (HCC) is often caused by hepatitis B virus (HBV) or hepatitis C virus (HCV) infection. To investigate the completeness of death certificates for recording viral hepatitis in HCC death, we compared the proportion of HCC deaths with hepatitis virus infection reported on death certificates to that reported as claims in the Surveillance, Epidemiology, and End Results (SEER)-Medicare database among individuals >= 66 years of age. For 2001-2015, we tabulated proportions of HCC deaths with HBV or HCV infection in each database overall, and by demographic factors. To correct for under ascertainment of viral hepatitis-associated HCC on death certificates, we multiplied by the reciprocal ratio of death certificates to SEER-Medicare. Among HCC decedents, HBV infection was reported on 3.6% of death certificates and 17.2% of Medicare claims. For HCV, corresponding proportions were 14.9% and 26.9%. The ratio of HBV-attributable HCC deaths in death certificates to SEER-Medicare remained similar to 0.21 over time. The ratio of HCV-attributable HCC deaths decreased 22.1% per year, from 0.70 in 2001 to 0.37 in 2003, and increased 4.1% per year, from 0.47 in 2004 to 0.66 in 2015. Following correction, the 2015 mortality rate from death certificate data increased from 0.2 to 0.9 per 100,000 for HBV-attributable HCC and from 2.3 to 3.5 per 100,000 for HCV-attributable HCC. In conclusion, among older Americans dying from HCC, death certificates captured 21% of HBV and 55% of HCV infections compared to Medicare claims. Our results suggest that death certificates provide incomplete data for viral hepatitis-associated HCC surveillance.
引用
收藏
页码:934 / 941
页数:8
相关论文
共 50 条
  • [1] COMPARING DEATH CERTIFICATES AND SEER-MEDICARE DATA FOR HEPATITIS VIRUS-ASSOCIATED LIVER CANCER MORTALITY
    Jiang, Joy
    Shiels, Meredith
    O'Brien, Thomas R.
    HEPATOLOGY, 2020, 72 : 385A - 385A
  • [2] Mortality associated with hepatitis C and hepatitis B virus infection: A nationwide study on multiple causes of death data
    Ugo Fedeli
    Enrico Grande
    Francesco Grippo
    Luisa Frova
    World Journal of Gastroenterology, 2017, (10) : 1866 - 1871
  • [3] Mortality associated with hepatitis C and hepatitis B virus infection: A nationwide study on multiple causes of death data
    Fedeli, Ugo
    Grande, Enrico
    Grippo, Francesco
    Frova, Luisa
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (10) : 1866 - 1871
  • [4] One year mortality following pancreatectomy for pancreatic cancer: analysis of the SEER-Medicare data
    Nayar, Preethy
    Are, Chandrakanth
    Yu, Fang
    Chandak, Aastha N.
    Gupta, Niodita
    CANCER RESEARCH, 2015, 75
  • [5] Postoperative Mortality Following Multi-Modality Therapy for Pancreatic Cancer: Analysis of the SEER-Medicare Data
    Nayar, Preethy
    Chandak, Aastha
    Gupta, Niodita
    Yu, Fang
    Qiu, Fang
    Ganti, Apar Kishor
    Are, Chandrakanth
    JOURNAL OF SURGICAL ONCOLOGY, 2017, 115 (02) : 158 - 163
  • [6] Increased breast cancer mortality due to treatment delay and needle biopsy type: a retrospective analysis of SEER-medicare
    Pathak, Rashmi
    Leslie, Macall
    Dondapati, Priya
    Davis, Rachel
    Tanaka, Kenichi
    Jett, Elizabeth
    Chervoneva, Inna
    Tanaka, Takemi
    BREAST CANCER, 2023, 30 (04) : 627 - 636
  • [7] Increased breast cancer mortality due to treatment delay and needle biopsy type: a retrospective analysis of SEER-medicare
    Rashmi Pathak
    Macall Leslie
    Priya Dondapati
    Rachel Davis
    Kenichi Tanaka
    Elizabeth Jett
    Inna Chervoneva
    Takemi Tanaka
    Breast Cancer, 2023, 30 : 627 - 636
  • [8] Liver cancer surveillance in people with hepatitis B in Africa
    Ndububa, Dennis A.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2024, 9 (06): : 491 - 492
  • [9] Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus
    Adachi, Shigeru
    Shibuya, Akitaka
    Miura, Yukiko
    Takeuchi, Atsuko
    Nakazawa, Takahide
    Saigenji, Katsunori
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2008, 43 (07) : 849 - 856
  • [10] Acute Liver Failure Due to Acute Hepatitis B Infection
    Kandel, Pujan
    McDonald, Philip
    Bachuwa, Ghassan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S1818 - S1818